Table 1.

Univariate Analysis of Clinical Parameters, with Overall Survival at Pre- and Postchemotherapy Time Points

	Prechemotherapy		Postchemotherapy
	Hazard Ratio	p Value	Hazard Ratio	p Value
Monocyte/lymphocyte ratio	3.244 (1.333–7.898)	9.53E−03	4.377 (1.93–9.927)	4.09E−04
EBV (/10,000)	1.006 (1.001–1.012)	1.38E−02	1.036 (1.014–1.059)	1.59E−03
Neutrophil count	1.15 (1.022–1.294)	2.00E−02	1.577 (1.113–2.235)	1.03E−02
Monocyte count	4.007 (0.7209–22.27)	1.13E−01	7.291 (1.469–36.18)	1.51E−02
WBC count	1.143 (1.012–1.291)	3.10E−02	1.375 (1.032–1.832)	2.94E−02
SII	1 (1–1)	1.20E−02	1 (1–1.001)	4.35E−02
Neutrophil/lymphocyte ratio	1.067 (1.009–1.129)	2.36E−02	1.141 (0.9955–1.308)	5.80E−02
Platelet count	1.004 (1.001–1.007)	2.26E−02	1.004 (0.999–1.008)	1.28E−01
Platelet/lymphocyte ratio	1.001 (1–1.002)	3.56E−02	1.001 (0.9993–1.003)	2.39E−01
Lymphocyte count	0.8174 (0.4433–1.507)	5.18E−01	0.8137 (0.4033–1.641)	5.65E−01
Eosinophil count	0.7771 (0.0394–15.33)	8.68E−01	1.743 (0.05878–51.69)	7.48E−01
Basophil count	7.645 (2.81E−07–2.08E+08)	8.16E−01	1.029 (1.39E−13–7.63E+12)	9.99E−01
Age	1.01 (0.9753–1.045)	5.84E−01	1.009 (0.9747–1.045)	6.06E−01
Sex	0.7134 (0.3259–1.562)	3.98E−01	0.7047 (0.3218–1.543)	3.82E−01

Cox proportional hazard model, hazard ratios shown with range in parentheses. SII, systemic immune-inflammation index; WBC, white blood cell. n = 34.